Physician profile
Michael Pylman
NPI 1407803893
$2,457.71
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $769 · 2020: $404 · 2021: $501 · 2022: $536 · 2023: $80.60 · 2024: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $246.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $369.78 | 2019-2020 | |
| Nevro Corp. | $269.21 | 2021-2023 | Senza |
| Abbvie INC. | $255.22 | 2021-2023 | |
| Teva Pharmaceuticals USA, INC. | $238.35 | 2019-2020 | |
| Amgen INC. | $205.55 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $148.55 | 2024 | Exparel |
| Novartis Pharmaceuticals Corporation | $133.74 | 2019-2021 | |
| Daiichi Sankyo INC. | $119.37 | 2019 | |
| Electronic Waveform Lab, INC. | $95.26 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $87.49 | 2021 | |
| Pfizer INC. | $79.97 | 2019-2020 | |
| Abbott Laboratories | $78.61 | 2021-2022 | |
| Grt US Holding, INC. | $76.27 | 2022 | |
| Scilex Pharmaceuticals INC. | $74.55 | 2019-2022 | |
| Lundbeck LLC | $64.66 | 2021-2023 | Vyepti |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $37.57 | 2020-2021 | |
| Allergan, INC. | $33.21 | 2019-2021 | |
| Zyla Life Sciences, INC. | $25.51 | 2019 | |
| Lilly USA, LLC | $18.05 | 2022 | |
| Mindray Ds USA, INC. | $17.84 | 2024 | Te X, Te7 Max |
| Indivior INC. | $15.50 | 2020 | |
| Bioventus LLC | $13.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Pylman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.